DLGAP1 and gastric cancer: In previous studies, DLGAP1‐AS1 was conformed to accelerate tumorigenesis and EMT process in hepatocellular carcinoma (Lin et al., 2020) and facilitate the cell invasion in gastric cancer (Deng et al., 2020).